Addition of Rituximab to Either BEAC or BEAM in the Preparative Regimen Prior to Autologous Stem Cell Transplantation in Patients With Relapsed B-Cell Non-Hodgkin Lymphoma Does Not Add a Survival Benefit: A Single Center Experience

✍ Scribed by C.B. Williams; A. Loknath-Kumar; C.L. Divine; O.A. Aljitawi; S. Abhyankar; J.P. McGuirk; S. Ganguly

• Book ID: 116282520
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 48 KB
• Volume: 17
• Category: Article
• ISSN: 1083-8791
• DOI: 10.1016/j.bbmt.2010.12.586